Open Access
Open access
volume 294 pages 120375

Gene therapy: Comprehensive overview and therapeutic applications

Nilofer Sayed 1
Prince Allawadhi 2
Amit Khurana 3, 4, 5, 6
Vishakha Singh 2
Umashanker Navik 7
Sravan Kumar Pasumarthi 8
Isha Khurana 9
Anil Kumar Banothu 10
Kala Kumar Bharani 12
1
 
Department of Pharmacy, Pravara Rural Education Society's (P.R.E.S.'s) College of Pharmacy, Shreemati Nathibai Damodar Thackersey (SNDT) Women's University, Nashik 400020, Maharashtra, India.
4
 
Department of Veterinary Pharmacology and Toxicology, College of Veterinary Science (CVSc), PVNRTVU, Rajendranagar, Hyderabad 500030, Telangana, India
5
 
Department of Veterinary Pharmacology and Toxicology, College of Veterinary Science (CVSc), PVNRTVU, Mamnoor, Warangal 506166, Telangana, India
8
 
The Business Research Company (TBRC), Jubilee Hills, Hyderabad 500033, Telangana, India.
10
 
Department of Veterinary Pharmacology and Toxicology, College of Veterinary Science (CVSc), PVNRTVU, Rajendranagar, Hyderabad 500030, Telangana, India.
12
 
Department of Veterinary Pharmacology and Toxicology, College of Veterinary Science (CVSc), PVNRTVU, Mamnoor, Warangal 506166, Telangana, India. Electronic address: bkalakumar@gmail.com.
Publication typeJournal Article
Publication date2022-04-01
scimago Q1
wos Q1
SJR1.315
CiteScore10.9
Impact factor5.1
ISSN00243205, 18790631
General Biochemistry, Genetics and Molecular Biology
General Medicine
General Pharmacology, Toxicology and Pharmaceutics
Abstract
Gene therapy is the product of man's quest to eliminate diseases. Gene therapy has three facets namely, gene silencing using siRNA, shRNA and miRNA, gene replacement where the desired gene in the form of plasmids and viral vectors, are directly administered and finally gene editing based therapy where mutations are modified using specific nucleases such as zinc-finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs) and clustered regulatory interspaced short tandem repeats (CRISPR)/CRISPR-associated protein (Cas)-associated nucleases. Transfer of gene is either through transformation where under specific conditions the gene is directly taken up by the bacterial cells, transduction where a bacteriophage is used to transfer the genetic material and lastly transfection that involves forceful delivery of gene using either viral or non-viral vectors. The non-viral transfection methods are subdivided into physical, chemical and biological. The physical methods include electroporation, biolistic, microinjection, laser, elevated temperature, ultrasound and hydrodynamic gene transfer. The chemical methods utilize calcium- phosphate, DAE-dextran, liposomes and nanoparticles for transfection. The biological methods are increasingly using viruses for gene transfer, these viruses could either integrate within the genome of the host cell conferring a stable gene expression, whereas few other non-integrating viruses are episomal and their expression is diluted proportional to the cell division. So far, gene therapy has been wielded in a plethora of diseases. However, coherent and innocuous delivery of genes is among the major hurdles in the use of this promising therapy. Hence this review aims to highlight the current options available for gene transfer along with the advantages and limitations of every method.
Found 
Found 

Top-30

Journals

1
2
3
4
5
6
7
8
9
International Journal of Biological Macromolecules
9 publications, 3.61%
International Journal of Molecular Sciences
6 publications, 2.41%
Pharmaceutics
6 publications, 2.41%
Frontiers in Bioengineering and Biotechnology
3 publications, 1.2%
Coordination Chemistry Reviews
3 publications, 1.2%
Journal of Materials Chemistry B
3 publications, 1.2%
Small
3 publications, 1.2%
International Journal of Nanomedicine
3 publications, 1.2%
Biomacromolecules
3 publications, 1.2%
ACS applied materials & interfaces
3 publications, 1.2%
Biomedicines
3 publications, 1.2%
International Journal of Pharmaceutics
3 publications, 1.2%
Bioengineering
2 publications, 0.8%
Pharmaceuticals
2 publications, 0.8%
Frontiers in Pharmacology
2 publications, 0.8%
Polymers
2 publications, 0.8%
Molecules
2 publications, 0.8%
Materials Today Bio
2 publications, 0.8%
PLoS ONE
2 publications, 0.8%
Molecular Biology Reports
2 publications, 0.8%
Asian Journal of Pharmaceutical Sciences
2 publications, 0.8%
Small Methods
2 publications, 0.8%
Scientific Reports
2 publications, 0.8%
ACS Applied Bio Materials
2 publications, 0.8%
Gene
2 publications, 0.8%
Naunyn-Schmiedeberg's Archives of Pharmacology
2 publications, 0.8%
Advanced Functional Materials
2 publications, 0.8%
Gene Therapy
2 publications, 0.8%
Molecular Pharmaceutics
2 publications, 0.8%
1
2
3
4
5
6
7
8
9

Publishers

10
20
30
40
50
60
70
Elsevier
68 publications, 27.31%
Springer Nature
44 publications, 17.67%
MDPI
39 publications, 15.66%
Wiley
24 publications, 9.64%
American Chemical Society (ACS)
18 publications, 7.23%
Taylor & Francis
9 publications, 3.61%
Royal Society of Chemistry (RSC)
8 publications, 3.21%
Frontiers Media S.A.
7 publications, 2.81%
Cold Spring Harbor Laboratory
5 publications, 2.01%
Bentham Science Publishers Ltd.
3 publications, 1.2%
Ovid Technologies (Wolters Kluwer Health)
2 publications, 0.8%
Public Library of Science (PLoS)
2 publications, 0.8%
Oxford University Press
2 publications, 0.8%
American Physiological Society
1 publication, 0.4%
Siberian State Medical University
1 publication, 0.4%
Shenyang Pharmaceutical University
1 publication, 0.4%
National Library of Serbia
1 publication, 0.4%
Volgograd State Medical University
1 publication, 0.4%
SPIE-Intl Soc Optical Eng
1 publication, 0.4%
Medknow
1 publication, 0.4%
OOO Zhurnal "Mendeleevskie Soobshcheniya"
1 publication, 0.4%
Mary Ann Liebert
1 publication, 0.4%
IOP Publishing
1 publication, 0.4%
Walter de Gruyter
1 publication, 0.4%
IMR Press
1 publication, 0.4%
American Society for Microbiology
1 publication, 0.4%
Allerton Press
1 publication, 0.4%
AME Publishing Company
1 publication, 0.4%
Jaypee Brothers Medical Publishing
1 publication, 0.4%
10
20
30
40
50
60
70
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
249
Share
Cite this
GOST |
Cite this
GOST Copy
Sayed N. et al. Gene therapy: Comprehensive overview and therapeutic applications // Life Sciences. 2022. Vol. 294. p. 120375.
GOST all authors (up to 50) Copy
Sayed N., Allawadhi P., Khurana A., Singh V., Navik U., Pasumarthi S. K., Khurana I., Banothu A. K., Weiskirchen R., Bharani K. K. Gene therapy: Comprehensive overview and therapeutic applications // Life Sciences. 2022. Vol. 294. p. 120375.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/j.lfs.2022.120375
UR - https://doi.org/10.1016/j.lfs.2022.120375
TI - Gene therapy: Comprehensive overview and therapeutic applications
T2 - Life Sciences
AU - Sayed, Nilofer
AU - Allawadhi, Prince
AU - Khurana, Amit
AU - Singh, Vishakha
AU - Navik, Umashanker
AU - Pasumarthi, Sravan Kumar
AU - Khurana, Isha
AU - Banothu, Anil Kumar
AU - Weiskirchen, Ralf
AU - Bharani, Kala Kumar
PY - 2022
DA - 2022/04/01
PB - Elsevier
SP - 120375
VL - 294
PMID - 35123997
SN - 0024-3205
SN - 1879-0631
ER -
BibTex
Cite this
BibTex (up to 50 authors) Copy
@article{2022_Sayed,
author = {Nilofer Sayed and Prince Allawadhi and Amit Khurana and Vishakha Singh and Umashanker Navik and Sravan Kumar Pasumarthi and Isha Khurana and Anil Kumar Banothu and Ralf Weiskirchen and Kala Kumar Bharani},
title = {Gene therapy: Comprehensive overview and therapeutic applications},
journal = {Life Sciences},
year = {2022},
volume = {294},
publisher = {Elsevier},
month = {apr},
url = {https://doi.org/10.1016/j.lfs.2022.120375},
pages = {120375},
doi = {10.1016/j.lfs.2022.120375}
}
Profiles